Vapreotide: Difference between revisions

Revision as of 11:56, 9 February 2025

Synthetic somatostatin analog

Vapreotide is a synthetic somatostatin analog used primarily in the treatment of certain types of cancer and gastrointestinal disorders. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

Pharmacology

Vapreotide is a cyclic peptide that acts as an agonist at somatostatin receptors. It has a high affinity for the somatostatin receptor subtypes 2, 3, and 5. By binding to these receptors, vapreotide inhibits the secretion of growth hormone, insulin, and glucagon.

Medical uses

Vapreotide is used in the management of acromegaly, a condition characterized by excessive production of growth hormone. It is also employed in the treatment of gastrointestinal bleeding associated with esophageal varices in patients with cirrhosis.

Mechanism of action

The drug works by mimicking the action of somatostatin, thereby reducing the secretion of various hormones and neurotransmitters. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.

Side effects

Common side effects of vapreotide include nausea, vomiting, diarrhea, and abdominal pain. Long-term use may lead to gallstone formation due to reduced gallbladder motility.

History

Vapreotide was developed as part of efforts to create longer-acting and more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine and gastrointestinal disorders.

Research

Ongoing research is exploring the use of vapreotide in other conditions, such as neuroendocrine tumors and pancreatic cancer. Studies are also investigating its efficacy in combination with other therapeutic agents.

Related pages

References

@@ Line 1: / Line 1: @@
-'''Vapreotide''' is a synthetic [[somatostatin]] analog that is used in the management of [[acromegaly]], a rare hormonal disorder that results from an excess of [[growth hormone]] in the body. It is also used to treat symptoms associated with [[metastatic]] [[carcinoid tumors]] and vasoactive intestinal peptide secreting tumors (VIPomas).
+{{Short description|Synthetic somatostatin analog}}
+{{Use dmy dates|date=October 2023}}
+[[File:Vapreotide.svg|thumb|Chemical structure of Vapreotide]]
+'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain types of [[cancer]] and [[gastrointestinal]] disorders. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.
-== Pharmacology ==
+==Pharmacology==
+Vapreotide is a [[cyclic peptide]] that acts as an agonist at somatostatin receptors. It has a high affinity for the [[somatostatin receptor]] subtypes 2, 3, and 5. By binding to these receptors, vapreotide inhibits the secretion of [[growth hormone]], [[insulin]], and [[glucagon]].
-Vapreotide, like natural somatostatin, inhibits the secretion of many hormones, including growth hormone, [[glucagon]], [[insulin]], and [[gastrin]]. It does this by binding to somatostatin receptors in the body, which are found in the [[pituitary gland]], the [[pancreas]], and certain parts of the [[stomach]] and [[intestines]]. By binding to these receptors, vapreotide inhibits the release of the aforementioned hormones, thereby helping to control symptoms in conditions where these hormones are overproduced.
+==Medical uses==
+Vapreotide is used in the management of [[acromegaly]], a condition characterized by excessive production of growth hormone. It is also employed in the treatment of [[gastrointestinal bleeding]] associated with [[esophageal varices]] in patients with [[cirrhosis]].
-== Clinical Use ==
+==Mechanism of action==
+The drug works by mimicking the action of somatostatin, thereby reducing the secretion of various hormones and [[neurotransmitters]]. This action helps in controlling symptoms associated with hormone-secreting tumors and other related conditions.
-Vapreotide is used in the treatment of acromegaly, a condition characterized by an overproduction of growth hormone, usually due to a benign tumor in the pituitary gland. By inhibiting the release of growth hormone, vapreotide can help to control the symptoms of this condition, which include enlarged hands and feet, facial changes, and joint pain.
+==Side effects==
+Common side effects of vapreotide include [[nausea]], [[vomiting]], [[diarrhea]], and [[abdominal pain]]. Long-term use may lead to [[gallstone]] formation due to reduced gallbladder motility.
-In addition, vapreotide is used to manage symptoms associated with metastatic carcinoid tumors and VIPomas. These are types of neuroendocrine tumors that can cause a variety of symptoms, including flushing, diarrhea, and wheezing, due to the overproduction of certain hormones. Vapreotide can help to control these symptoms by inhibiting the release of these hormones.
+==History==
+Vapreotide was developed as part of efforts to create longer-acting and more potent analogs of somatostatin. It has been studied extensively for its potential benefits in treating various endocrine and gastrointestinal disorders.
-== Side Effects ==
+==Research==
+Ongoing research is exploring the use of vapreotide in other conditions, such as [[neuroendocrine tumors]] and [[pancreatic cancer]]. Studies are also investigating its efficacy in combination with other therapeutic agents.
-Like all medications, vapreotide can cause side effects. The most common side effects include [[nausea]], [[pain]] at the injection site, [[gallstones]], and changes in [[blood sugar]] levels. In rare cases, vapreotide can cause serious side effects, such as [[heart problems]], [[liver problems]], and [[allergic reactions]].
-== See Also ==
+==Related pages==
 * [[Somatostatin]]
+* [[Somatostatin receptor]]
 * [[Acromegaly]]
-* [[Carcinoid Syndrome]]
+* [[Esophageal varices]]
-* [[VIPoma]]
+==References==
+{{Reflist}}
-[[Category:Drugs]]
+[[Category:Peptides]]
-[[Category:Endocrinology]]
+[[Category:Hormones]]
-[[Category:Pharmacology]]
+[[Category:Antineoplastic and immunomodulating agents]]
-{{Pharma-stub}}
+[[Category:Somatostatin receptor agonists]]